Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Eupraxia Pharmaceuticals Inc (TO: EPRX)

 
EPRX Technical Analysis
5
As on 20th Dec 2024 EPRX STOCK Price closed @ 4.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.91 & Strong Sell for SHORT-TERM with Stoploss of 7.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EPRXSTOCK Price

Open 4.40 Change Price %
High 4.41 1 Day -0.06 -1.37
Low 4.30 1 Week -0.32 -6.88
Close 4.33 1 Month -0.03 -0.69
Volume 4800 1 Year -4.57 -51.35
52 Week High 8.90 | 52 Week Low 3.15
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
CNQ 42.50 0.05%
ENB 59.43 1.49%
BB 5.27 23.13%
ABX 22.22 1.41%
TWM 0.12 0.00%
FCU 0.74 -2.63%
PPL 52.36 0.89%
CVE 20.71 0.24%
TD 76.09 0.44%
 
TO Canada Top Gainers Stocks
CUB 0.21 950.00%
CUB 0.21 950.00%
BNG 0.02 100.00%
APS 0.42 75.00%
APS 0.42 75.00%
APS 0.42 75.00%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
 
 
EPRX
Daily Charts		 EPRX
Intraday Charts		 Whats New @
Bazaartrend		 EPRX
Free Analysis
 
EPRX Important Levels Intraday
RESISTANCE4.54
RESISTANCE4.47
RESISTANCE4.43
RESISTANCE4.39
SUPPORT4.27
SUPPORT4.23
SUPPORT4.19
SUPPORT4.12
 
EPRX Forecast December 2024
Share
4th UP Forecast7.18
3rd UP Forecast6.27
2nd UP Forecast5.7
1st UP Forecast5.14
1st DOWN Forecast3.52
2nd DOWN Forecast2.96
3rd DOWN Forecast2.39
4th DOWN Forecast1.48
 
EPRX Weekly Forecast
4th UP Forecast6.95
3rd UP Forecast6.11
2nd UP Forecast5.59
1st UP Forecast5.07
1st DOWN Forecast3.59
2nd DOWN Forecast3.07
3rd DOWN Forecast2.55
4th DOWN Forecast1.71
 
EPRX Forecast2024
4th UP Forecast15.85
3rd UP Forecast12.16
2nd UP Forecast9.87
1st UP Forecast7.59
1st DOWN Forecast1.07
2nd DOWN Forecast-1.21
3rd DOWN Forecast-3.5
4th DOWN Forecast-7.19
 
 
EPRX Other Details
Segment EQ
Market Capital 30621592.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EPRX Address
EPRX
 
EPRX Latest News
 
Your Comments and Response on Eupraxia Pharmaceuticals Inc
 
EPRX Business Profile
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Address: 2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service